Research Article
The Diagnostic Role of Adiponectin in Pulmonary Embolism
Table 1
Baseline characteristics in the study groups.
| | | Control group () | PTE group () | |
| | Age (years) | 59.48 ± 15.76 | 60.05 ± 18.38 | NS | | Sex (male/female) | 23/34 | 14/24 | NS | | Heart rate (beat/min) | 99.79 ± 21.69 | 105.97 ± 21.20 | NS | | Wells score | 4.07 ± 1.90 | 5.04 ± 1.95 | <0.05 | | Geneva score | 6.03 ± 2.08 | 7.30 ± 2.39 | <0.05 | | D-dimer (ng/mL) |
2211.21 ± 1765.53 |
4241.66 ± 1082.98 | <0.05 | | Adiponectin (μg/mL) | 7.68 ± 4.67 | 5.46 ± 4.39 | <0.05 | | WBC count (103/μL) | 6.8 ± 1.9 | 7.1 ± 2.3 | NS | | Platelet count (103/μL) | 228 ± 61 | 242 ± 73 | NS | | Hemoglobin (g/dL) | 13.8 ± 1.3 | 13.5 ± 1.6 | NS |
|
|
PTE: pulmonary thromboembolism; was accepted as statistically significant.
Wells score clinical probability: 0-1: low, 2–6: intermediate, >7: high.
Geneva score clinical probability: 0–3: low, 4–10: intermediate, >11: high.
|
